#equity-offering

Symbiotec Pharmalab IPO opens with strong GMP signals

Symbiotec Pharmalab launched its Rs 1,757 crore IPO on August 24, 2026, consisting mainly of an offer for sale with a small fresh issue. The price band is Rs 938-988, and early market sentiment points to a potential listing premium, while concerns about profitability and plant ramp-ups persist.